CROWDSTRIKE HOLDINGS INC - A (CRWD) Fundamental Analysis & Valuation

NASDAQ:CRWD • US22788C1053

Current stock price

390.41 USD
+10.35 (+2.72%)
At close:
395.98 USD
+5.57 (+1.43%)
Pre-Market:

This CRWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CRWD Profitability Analysis

1.1 Basic Checks

  • CRWD had positive earnings in the past year.
  • In the past year CRWD had a positive cash flow from operations.
  • In the past 5 years CRWD reported 4 times negative net income.
  • In the past 5 years CRWD always reported a positive cash flow from operatings.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B

1.2 Ratios

  • CRWD's Return On Assets of -1.47% is in line compared to the rest of the industry. CRWD outperforms 52.73% of its industry peers.
  • Looking at the Return On Equity, with a value of -3.67%, CRWD is in line with its industry, outperforming 54.91% of the companies in the same industry.
Industry RankSector Rank
ROA -1.47%
ROE -3.67%
ROIC N/A
ROA(3y)-0.11%
ROA(5y)-2.1%
ROE(3y)-0.13%
ROE(5y)-7.16%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1K -2K -3K

1.3 Margins

  • CRWD's Gross Margin of 74.81% is fine compared to the rest of the industry. CRWD outperforms 66.55% of its industry peers.
  • CRWD's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CRWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y0.29%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100 -150 -200

6

2. CRWD Health Analysis

2.1 Basic Checks

  • CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CRWD has about the same amount of shares outstanding.
  • CRWD has more shares outstanding than it did 5 years ago.
  • CRWD has a better debt/assets ratio than last year.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 9.48 indicates that CRWD is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CRWD (9.48) is better than 92.00% of its industry peers.
  • The Debt to FCF ratio of CRWD is 0.60, which is an excellent value as it means it would take CRWD, only 0.60 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.60, CRWD is in the better half of the industry, outperforming 77.09% of the companies in the same industry.
  • A Debt/Equity ratio of 0.17 indicates that CRWD is not too dependend on debt financing.
  • CRWD has a Debt to Equity ratio (0.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 0.6
Altman-Z 9.48
ROIC/WACCN/A
WACC10.97%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1B 2B 3B 4B

2.3 Liquidity

  • CRWD has a Current Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
  • CRWD has a Current ratio (1.77) which is comparable to the rest of the industry.
  • CRWD has a Quick Ratio of 1.77. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
  • CRWD has a Quick ratio (1.77) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B

8

3. CRWD Growth Analysis

3.1 Past

  • The earnings per share for CRWD have decreased by -4.83% in the last year.
  • The Earnings Per Share has been growing by 70.44% on average over the past years. This is a very strong growth
  • CRWD shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.71%.
  • The Revenue has been growing by 40.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-4.83%
EPS 3Y34.42%
EPS 5Y70.44%
EPS Q2Q%8.74%
Revenue 1Y (TTM)21.71%
Revenue growth 3Y29.01%
Revenue growth 5Y40.64%
Sales Q2Q%23.32%

3.2 Future

  • CRWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.24% yearly.
  • Based on estimates for the next years, CRWD will show a very strong growth in Revenue. The Revenue will grow by 21.55% on average per year.
EPS Next Y31.1%
EPS Next 2Y28.67%
EPS Next 3Y28.19%
EPS Next 5Y27.24%
Revenue Next Year22.98%
Revenue Next 2Y22.27%
Revenue Next 3Y21.97%
Revenue Next 5Y21.55%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 5B 10B 15B 20B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 5 10 15 20 25

2

4. CRWD Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 104.39, the valuation of CRWD can be described as expensive.
  • CRWD's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.35, CRWD is valued quite expensively.
  • CRWD is valuated quite expensively with a Price/Forward Earnings ratio of 79.62.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CRWD.
  • CRWD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 104.39
Fwd PE 79.62
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • CRWD's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CRWD.
Industry RankSector Rank
P/FCF 79.75
EV/EBITDA 1494.86
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CRWD's earnings are expected to grow with 28.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.36
PEG (5Y)1.48
EPS Next 2Y28.67%
EPS Next 3Y28.19%

0

5. CRWD Dividend Analysis

5.1 Amount

  • CRWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CRWD Fundamentals: All Metrics, Ratios and Statistics

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (3/31/2026, 8:27:31 PM)

Premarket: 395.98 +5.57 (+1.43%)

390.41

+10.35 (+2.72%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03
Earnings (Next)06-01
Inst Owners74.99%
Inst Owner Change2.25%
Ins Owners2.96%
Ins Owner Change0.57%
Market Cap99.01B
Revenue(TTM)4.81B
Net Income(TTM)-162.50M
Analysts76.33
Price Target492.95 (26.26%)
Short Float %3.09%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.16%
Min EPS beat(2)-0.35%
Max EPS beat(2)0.03%
EPS beat(4)3
Avg EPS beat(4)4.73%
Min EPS beat(4)-0.35%
Max EPS beat(4)9.95%
EPS beat(8)7
Avg EPS beat(8)7.19%
EPS beat(12)11
Avg EPS beat(12)9.98%
EPS beat(16)15
Avg EPS beat(16)13.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-1%
Min Revenue beat(4)-2%
Max Revenue beat(4)-0.26%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)3
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.16%
PT rev (1m)-11.23%
PT rev (3m)-11.04%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 104.39
Fwd PE 79.62
P/S 20.58
P/FCF 79.75
P/OCF 61.41
P/B 22.36
P/tB 33.81
EV/EBITDA 1494.86
EPS(TTM)3.74
EY0.96%
EPS(NY)4.9
Fwd EY1.26%
FCF(TTM)4.9
FCFY1.25%
OCF(TTM)6.36
OCFY1.63%
SpS18.97
BVpS17.46
TBVpS11.55
PEG (NY)3.36
PEG (5Y)1.48
Graham Number38.33
Profitability
Industry RankSector Rank
ROA -1.47%
ROE -3.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.81%
FCFM 25.8%
ROA(3y)-0.11%
ROA(5y)-2.1%
ROE(3y)-0.13%
ROE(5y)-7.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5Y0.29%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 0.6
Debt/EBITDA 11.79
Cap/Depr 131.77%
Cap/Sales 7.71%
Interest Coverage N/A
Cash Conversion 2549.77%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 9.48
F-Score4
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)147.23%
Cap/Depr(5y)184%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.83%
EPS 3Y34.42%
EPS 5Y70.44%
EPS Q2Q%8.74%
EPS Next Y31.1%
EPS Next 2Y28.67%
EPS Next 3Y28.19%
EPS Next 5Y27.24%
Revenue 1Y (TTM)21.71%
Revenue growth 3Y29.01%
Revenue growth 5Y40.64%
Sales Q2Q%23.32%
Revenue Next Year22.98%
Revenue Next 2Y22.27%
Revenue Next 3Y21.97%
Revenue Next 5Y21.55%
EBIT growth 1Y-85.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.98%
EBIT Next 3Y39.73%
EBIT Next 5YN/A
FCF growth 1Y16.25%
FCF growth 3Y22.55%
FCF growth 5Y33.5%
OCF growth 1Y16.69%
OCF growth 3Y19.66%
OCF growth 5Y35.23%

CROWDSTRIKE HOLDINGS INC - A / CRWD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CROWDSTRIKE HOLDINGS INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to CRWD.


Can you provide the valuation status for CROWDSTRIKE HOLDINGS INC - A?

ChartMill assigns a valuation rating of 2 / 10 to CROWDSTRIKE HOLDINGS INC - A (CRWD). This can be considered as Overvalued.


What is the profitability of CRWD stock?

CROWDSTRIKE HOLDINGS INC - A (CRWD) has a profitability rating of 3 / 10.


What are the PE and PB ratios of CROWDSTRIKE HOLDINGS INC - A (CRWD) stock?

The Price/Earnings (PE) ratio for CROWDSTRIKE HOLDINGS INC - A (CRWD) is 104.39 and the Price/Book (PB) ratio is 22.36.


Can you provide the financial health for CRWD stock?

The financial health rating of CROWDSTRIKE HOLDINGS INC - A (CRWD) is 6 / 10.